• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[建立并优化幽门螺杆菌常规耐药性检测以促进基于耐药性的治疗]

[Establishment and optimization of a routinely resistance testing of Helicobacter pylori to encourage a resistance-guided therapy].

作者信息

Hildebrandt Anke, Bornemann Reinhard

机构信息

Medizinische Klinik I, St. Vincenz-Krankenhaus, Datteln, Germany.

Institut für Medizinische Mikrobiologie, Universität Münster, Münster, Germany.

出版信息

Z Gastroenterol. 2025 Sep;63(9):922-929. doi: 10.1055/a-2645-6481. Epub 2025 Sep 11.

DOI:10.1055/a-2645-6481
PMID:40934943
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12425596/
Abstract

The treatment of infection, so far, focussed on empirical antibiotic regimens. Facing increasing resistance dynamics and regionally different resistance patterns, however, resistance testing respectively resistance-guided therapy appears to be more appropriate. This helds not only in order to increase the effectiveness of individual therapy, but also in the sense of antibiotic stewardship. In particular, in the context of predominantly gastroscopic diagnostics, various options for resistance testing using culture and PCR are available. Thus, the optimal resistance-oriented therapy regimens can be derived on an individual basis.

摘要

到目前为止,感染的治疗主要集中在经验性抗生素治疗方案上。然而,面对日益增加的耐药动态和地区性不同的耐药模式,耐药性检测以及耐药性引导的治疗似乎更为合适。这不仅是为了提高个体治疗的有效性,也是从抗生素管理的角度而言。特别是在主要进行胃镜诊断的情况下,可以采用多种利用培养和PCR进行耐药性检测的方法。因此,可以根据个体情况制定最佳的以耐药性为导向的治疗方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76eb/12425596/41ec3c728eea/10-1055-a-2645-6481_26456324.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76eb/12425596/41ec3c728eea/10-1055-a-2645-6481_26456324.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76eb/12425596/41ec3c728eea/10-1055-a-2645-6481_26456324.jpg

相似文献

1
[Establishment and optimization of a routinely resistance testing of Helicobacter pylori to encourage a resistance-guided therapy].[建立并优化幽门螺杆菌常规耐药性检测以促进基于耐药性的治疗]
Z Gastroenterol. 2025 Sep;63(9):922-929. doi: 10.1055/a-2645-6481. Epub 2025 Sep 11.
2
antibiotic resistance: a global challenge in search of solutions.抗生素耐药性:寻求解决方案的全球挑战。
Gut. 2025 Jul 11. doi: 10.1136/gutjnl-2025-335523.
3
First regional consensus on the management of infection in the Middle East.中东地区关于感染管理的首个区域共识。
World J Gastroenterol. 2025 Jul 21;31(27):107138. doi: 10.3748/wjg.v31.i27.107138.
4
Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis.亚太地区幽门螺杆菌的主要抗生素耐药性:系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2017 Oct;2(10):707-715. doi: 10.1016/S2468-1253(17)30219-4. Epub 2017 Aug 7.
5
Eradication of for prevention of aspirin-associated peptic ulcer bleeding in adults over 65 years: the HEAT RCT.根除幽门螺杆菌预防65岁以上成年人阿司匹林相关消化性溃疡出血:HEAT随机对照试验
Health Technol Assess. 2025 Aug;29(42):1-62. doi: 10.3310/LLKF7871.
6
Efficacy of susceptibility-guided quadruple therapy with antibiotic resistance using the string test coupled with quantitative PCR for eradication: a protocol of a multicentre, open, randomised clinical trial.使用串珠试验结合定量PCR进行药敏指导的四重抗生素耐药治疗根除幽门螺杆菌的疗效:一项多中心、开放、随机临床试验方案
BMJ Open. 2024 Dec 20;14(12):e088788. doi: 10.1136/bmjopen-2024-088788.
7
Novel chromogenic medium-based method for the rapid detection of drug resistance.基于新型显色培养基的耐药性快速检测方法。
World J Gastroenterol. 2025 Aug 28;31(32):106424. doi: 10.3748/wjg.v31.i32.106424.
8
Optimum duration of regimens for Helicobacter pylori eradication.幽门螺杆菌根除治疗方案的最佳疗程
Cochrane Database Syst Rev. 2013 Dec 11;2013(12):CD008337. doi: 10.1002/14651858.CD008337.pub2.
9
Clinical evaluation of a novel fecal molecular diagnosis kit (multiplex RT-PCR method) for detecting clarithromycin and fluoroquinolones resistance using stool samples.一种新型粪便分子诊断试剂盒(多重逆转录聚合酶链反应法)用于通过粪便样本检测克拉霉素和氟喹诺酮类耐药性的临床评估。
Front Cell Infect Microbiol. 2025 Jun 23;15:1592612. doi: 10.3389/fcimb.2025.1592612. eCollection 2025.
10
Clinical evaluation of personalized treatment guided by PCR detection from fecal samples: a real-world study.粪便样本PCR检测指导下的个性化治疗的临床评估:一项真实世界研究
Front Cell Infect Microbiol. 2025 Apr 28;15:1519804. doi: 10.3389/fcimb.2025.1519804. eCollection 2025.

本文引用的文献

1
The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance.《2024年世界卫生组织细菌重点病原体清单》:一项用于指导针对抗菌药物耐药性的研究、开发及公共卫生策略的优先级排序研究。
Lancet Infect Dis. 2025 Apr 11. doi: 10.1016/S1473-3099(25)00118-5.
2
[1983-2023 - Four decades Helicobacter pylori - what's next?].
Z Gastroenterol. 2024 Apr;62(4):512-516. doi: 10.1055/a-2207-7185. Epub 2024 Jan 18.
3
Brief communication: global temporal trends in the efficacy of clarithromycin-based regimens for the treatment of infection.简短通讯:基于克拉霉素的治疗方案治疗感染的疗效的全球时间趋势
Therap Adv Gastroenterol. 2023 Jun 22;16:17562848231167284. doi: 10.1177/17562848231167284. eCollection 2023.
4
Eradication rates of Helicobacter pylori in treatment-naive patients following 14-day vonoprazan-amoxicillin dual therapy: A multicenter randomized controlled trial in China.在未经治疗的患者中,14 天 vonoprazan-阿莫西林双联疗法根除幽门螺杆菌的疗效:中国多中心随机对照试验。
Helicobacter. 2023 Aug;28(4):e12970. doi: 10.1111/hel.12970. Epub 2023 May 9.
5
[Not Available].[无可用内容]。
Z Gastroenterol. 2023 May;61(5):544-606. doi: 10.1055/a-1975-0414. Epub 2023 May 5.
6
Belgian consensus for Helicobacter pylori management 2023.《2023年比利时幽门螺杆菌管理共识》
Acta Gastroenterol Belg. 2023 Jan-Mar;86(1):74-91. doi: 10.51821/86.1.11327.
7
Effect of metronidazole resistance on Helicobacter pylori eradication regimens.甲硝唑耐药性对幽门螺杆菌根除方案的影响。
J Dig Dis. 2022 Oct;23(10):561-567. doi: 10.1111/1751-2980.13142. Epub 2022 Dec 26.
8
Vonoprazan Triple and Dual Therapy for Helicobacter pylori Infection in the United States and Europe: Randomized Clinical Trial.Vonoprazan 三联和双联疗法治疗美国和欧洲的幽门螺杆菌感染:随机临床试验。
Gastroenterology. 2022 Sep;163(3):608-619. doi: 10.1053/j.gastro.2022.05.055. Epub 2022 Jun 6.
9
[Important rise in antibiotic resistance rates inHelicobacter pyloriin the Netherlands].[荷兰幽门螺杆菌抗生素耐药率显著上升]
Ned Tijdschr Geneeskd. 2022 Mar 14;166:D6434.
10
Comparison of Culture With Antibiogram to Next-Generation Sequencing Using Bacterial Isolates and Formalin-Fixed, Paraffin-Embedded Gastric Biopsies.使用细菌分离株和福尔马林固定、石蜡包埋的胃活检标本进行培养和抗生素药敏试验与下一代测序的比较。
Gastroenterology. 2021 Nov;161(5):1433-1442.e2. doi: 10.1053/j.gastro.2021.07.012. Epub 2021 Jul 19.